drugset / Trial / NCT04528771
S-Nitrosylation Therapy of COVID-19
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective of this study is to provide expanded access of S-nitrosylation therapy for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV2) infection.
Timeline
- Start
- 2021-08-05
- Primary completion
- 2025-03-31
- Completion
- 2025-04-30
Outcome
Outcome not reported
Stopped: “Study delays”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SNO | Unknown | 80 ppm | Inhaled |